We are 1-Chlorocarbonyl-3-Methanesulfonyl-2-Imidazolidinone CAS:41762-76-9 manufacturer and supplier in China, Pls send inquiry of to email@example.com of visit www.nbinno.com our official website should you have any interests
Chemical Name: 1-Chlorocarbonyl-3-Methanesulfonyl-2-Imidazolidinone
Molecular Formula: C5H7ClN2O4S
Molecular Weight: 226.63800
Physical and Chemical Properties:
Density: 1.71 g / cm3
Boiling point: 347.9ºC at 760 mmHg
Melting point: 168-173 ° C (lit.)
Flash point: 164.2ºC
Refractive index: 1.594
Appearance:White to off-white Powder
Arsenic (As):1ppm max.
Heavy Metals (as Pb):10ppm max.
Iron (Fe):10ppm max.
Loss on Drying:0.3% max.
Solubility:Solubility in water: soluble in water: 53g/L (20°C).
Transmittance:98% min. (c=3, H2O, 430nm) 1cm cell
Specific Rotation Condition:− 24.00 (20.00°C c=8,6N HCl)
Other Amino Acids:(TLC) not detectable
Specific Rotation:− 24.00
Sulfated Ash:0.1% max.
Chlorine (Cl):300ppm max.
25kg cardboard drum or according to customer specified requirements
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Intermediates of Mezlocillin CAS:51481-65-3.
Related News: Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.3-Pyridylacetic Acid Hydrochloride The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.1-(7-broMo-9,9-difluoro-9H-fluoren-2-yl)-2-chloro-Ethanone CAS:1378387-81-5 DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation.3,5-difluoropiridina-2,6-diamina CAS:247069-27-8 DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation.The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances.